PDS Biotechnology Corporation (NASDAQ:PDSB) stock has reached a 52-week low, trading at $1.3, as investors navigate a ...

What Happened? Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.6% in the morning session after the ...

Investors have watched Wall Street's major market averages fall on Wednesday while yields jumped in response to the latest ...

Today was a big day for one small cap biotech company. The company announced that they had acquired worldwide exclusive ...

Monex Group, the Japan-based financial services company, has reported a net loss of $67 million (¥9.9 billion) for the third quarter of the fiscal year 2025.

Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to ...

Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target on Travere Therapeutics (NASDAQ:TVTX) to $32.00, up from the previous $27.00, while retaining a Sector Outperform rating for the ...

Markets took a sharp downward turn on Wall Street after U.S. government data Wednesday showed that inflation accelerated last ...

Vertex Pharmaceuticals (NASDAQ:VRTX) received an upgrade from Canaccord Genuity after the cystic fibrosis drugmaker exceeded consensus revenue estimates but missed on earnings with its Q4 2024 ...

Canaccord Genuity maintained a Buy rating on Verona Pharma (NASDAQ:VRNA) while significantly increasing the price target to $72.00 from the previous $44.00. According to InvestingPro data, analyst ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Adial Pharmaceuticals received a U.S. patent for genetic marker-based treatment methods and completed a pharmacokinetics ...